Skip to main content
BEAM
NASDAQ Life Sciences

Beam Therapeutics Posts $1.28 Per-Share Loss for Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$25.87
Mkt Cap
$2.672B
52W Low
$20.23
52W High
$38.26
52W Position info
28% above low
Off High info
32% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BEAM sits 28% above its 52-week low of $20.23.

Summary

Beam reported a third-quarter loss of $1.28 per share, per Dow Jones Newswires, wider than analysts expected as revenue dropped. That follows a $122.7M net loss in Q2, when the company held $1.2B in cash; the company ended 3Q 2026 with $1B in cash, cash equivalents and marketable securities, and its cash runway is expected to support operating plans into mid-2029. The stock sits at $25.87 after a rough stretch: shares fell 9% to $26.88 on September 8 when updated BEAM-302 AATD data showed total AAT levels declining, and the September 8 release had already framed BEAM-302 pivotal dosing and BEAM-304 IND clearance as the next clinical milestones. The wider-than-expected loss puts more pressure on a name already trading below its post-data level. Watch the BEAM-302 pivotal dosing update and BEAM-304 IND clearance as the events that decide the story from here.

At the time of this announcement, BEAM was trading at $25.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $20.23 to $38.26. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BEAM - Latest Insights

BEAM
Nov 10, 2026, 7:03 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $27.40
Real-time Price: $21.31 info
Change: -$6.09 (-22%) info
Market Cap: $2.209B info
BEAM
Nov 03, 2026, 8:34 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.31
Real-time Price: $21.31 info
Change: -$4.00 (-16%) info
Market Cap: $2.209B info
BEAM
Oct 13, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $25.47
Real-time Price: $21.31 info
Change: -$4.16 (-16%) info
Market Cap: $2.209B info
BEAM
Sep 08, 2026, 3:24 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $26.94
Real-time Price: $21.31 info
Change: -$5.63 (-21%) info
Market Cap: $2.209B info
BEAM
Sep 08, 2026, 9:22 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $25.95
Real-time Price: $21.31 info
Change: -$4.64 (-18%) info
Market Cap: $2.209B info